Active substance (DCI)
- ixazomib
history (5)
-
3/30/22
NINLARO (ixazomib) - Myélome
CAV : -
9/9/20
NINLARO
CAV : -
11/22/17
NINLARO (ixazomib)
CAV : -
2/21/18
NINLARO (ixazomib), antineoplastic agent
CAV :
Technical information
ATC code
- L01XG03
Manufacturer
TAKEDA FRANCE
Presentation
NINLARO 2,3 mg, gélule (code CIS : 69663414)
3 plaquette(s) PVC aluminium de 1 gélule(s) - (Code CIP : 34009 300 776 9 6)
NINLARO 3,0 mg, gélule (code CIS : 66833683)
3 plaquette(s) PVC aluminium de 1 gélule(s) - (Code CIP : 34009 300 777 1 9)
NINLARO 4,0 mg, gélule (code CIS : 69537091)
3 plaquette(s) PVC aluminium de 1 gélule(s) - (Code CIP : 34009 300 777 2 6)